Figure 6 of
Arslan, Mol Vis 2025; 31:142-157.
Figure 6.
Viability assay to evaluate the formulations’ toxicological formations.
Figure 6 of
Arslan, Mol Vis 2025; 31:142-157. Figure 6 of
Arslan, Mol Vis 2025; 31:142-157. 